Rivaroxaban Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Anticoagulants and protamine | Cardiovascular System
Items (12m)
983
Total Quantity
13.7K
NHS Cost
£9.6K
vs National Avg
+60.7%
MAPLE ACCESS PARTNERSHIP LLP prescribed 983 items of Rivaroxaban over the last 12 months at a cost of £9,594 to the NHS. This is 60.7% above the national average prescribing rate. Rivaroxaban is classified under Anticoagulants and protamine in the BNF.
Monthly Prescribing Trend
Jun 2026
86
Jun 2026
86
Jun 2026
85
Jun 2026
81
Jun 2026
83
Jun 2026
92
Jun 2026
76
Jun 2026
75
Jun 2026
83
Jun 2026
80
Jun 2026
83
Jun 2026
73
Prescribing Details
| Total Items | 983 |
|---|---|
| Total Quantity | 13,701 |
| Total NHS Cost | £9,594 |
| Presentations | 5 different forms |
| vs National Average | +60.7% |
Rivaroxaban Prescribing Comparison
| This practice | 983 items |
|---|---|
| National average per practice | 612 items |
| Difference | +60.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.